Assembly Biosciences (ASMB) Total Non-Current Liabilities (2014 - 2018)

Assembly Biosciences' Total Non-Current Liabilities history runs 5 years deep, the most recent figure standing at $38.9 million for Q4 2018.

• In Q4 2018, Total Non-Current Liabilities fell 8.84% year-over-year to $38.9 million; the TTM figure through Dec 2018 stood at $38.9 million (down 8.84% YoY), while the FY2018 annual figure was $38.9 million, down 8.84% from the prior year.
• Total Non-Current Liabilities was $38.9 million for Q4 2018 at Assembly Biosciences, roughly flat from $38.9 million in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $55.4 million in Q1 2017 to a low of $11.1 million in Q4 2016.
• Historically, Total Non-Current Liabilities has averaged $28.6 million across 5 years, with a median of $25.3 million in 2014.
• The sharpest annual moves came in 2017 and 2018: Total Non-Current Liabilities jumped 377.93% in 2017, then declined 26.49% in 2018.
• A 5-year view of Total Non-Current Liabilities shows it stood at $11.6 million in 2014, then changed by 0.0% to $11.6 million in 2015, then dropped by 4.14% to $11.1 million in 2016, then surged by 283.93% to $42.7 million in 2017, then declined by 8.84% to $38.9 million in 2018.
• The last three Total Non-Current Liabilities figures came in at $38.9 million (Q4 2018), $38.9 million (Q3 2018), and $40.2 million (Q2 2018), per Business Quant data.